Newsroom

ATHENS, Greece--(BUSINESS WIRE)--Piraeus Bank S.A. (ATHEX: TPEIR) (OTCQX: BPIRY) (OTCQX: BPIRF) Q3 and 9M 2026 highlights Broad-based growth in lending and client assets Loans reached €39.6bn, following €2.2bn net credit expansion in 9M, keeping Piraeus on track to meet its 2026 target of more than €3bn Mortgage recovery continues, with €135mn net increase in 9M and €0.6bn disbursements, +37% yoy Strong growth in client deposits +9% yoy, to €69.2bn, at 0.39% total cost Client AuMs +19% yoy at €...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

PARIS--(BUSINESS WIRE)--Regulatory News: In accordance with Article 5 of EU Regulation n° 596/2014 (Market Abuse Regulation), detailed information is available on the website of Tikehau Capital (Paris:TKO): https://www.tikehaucapital.com/fr/shareholders/regulatory-information Name of the issuer Issuer Identity Code (LEI) Trading Day ISIN Aggregated volume per day (number of shares) Weighted average price per day Market (MIC Code) TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 23/10/2026 FR0013230612 9 82...

PARIS--(BUSINESS WIRE)--Regulatory News: Conformément à l’article 5 du Règlement européen n° 596/2014 (Règlement MAR – Market Abuse Regulation), les informations détaillées sont disponibles sur le site de Tikehau Capital (Paris:TKO) : https://www.tikehaucapital.com/fr/shareholders/regulatory-information Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code identifiant de l'instrument financier Volume total journalier (en nombre de titres) Prix pondéré moyen jou...

SASKATOON, Saskatchewan--(BUSINESS WIRE)--Cameco (TSX: CCO; NYSE: CCJ) today reported its consolidated financial and operating results for the third quarter ended September 30, 2026....

OAKVILLE, Ontario--(BUSINESS WIRE)--Algonquin Power & Utilities Corp. (TSX/NYSE: AQN) (“AQN”) today announced plans to release its third quarter 2026 financial results on Friday, November 6, 2026, before market open. AQN will hold an earnings conference call at 8:30 a.m. eastern time on Friday, November 6, 2026, hosted by Chief Executive Officer, Rod West, and Chief Financial Officer, Rob Stefani. Conference call details are as follows: Date: Friday, November 6, 2026 Time: 8:30 a.m. ET Conf...

DAVIDSON, N.C.--(BUSINESS WIRE)--Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, today announced leadership appointments that reflect the scale of its businesses and position the company for its next phase of growth. Scott Watson has been named senior vice president and group president, Industrial Technologies and Services (IT&S) North America and EMEIA, and Shaun Carlson has been named senior vice president and...

SAN DIEGO--(BUSINESS WIRE)--Setara Biosciences, Inc. (Setara), a clinical-stage biotechnology company leveraging genetics to develop precision medicines for severe rare diseases, today announced the completion of a $90 million Series A financing. Setara was formed following the closing of Jazz Pharmaceuticals’ acquisition of Actio Biosciences (Actio) for its lead program ABS-1230, an investigational therapy for KCNT1-related epilepsy. Setara intends to advance Actio’s remaining pipeline, led by...

SPRING, Texas--(BUSINESS WIRE)--ExxonMobil Holdings Corporation (NYSE:XOM): Results Summary 3Q26 2Q26 Change vs 2Q26 Dollars in millions (except per share data) YTD 2026 YTD 2025 Change vs YTD 2025 15,413 14,525 +888 Earnings (U.S. GAAP) 34,121 22,343 +11,778               17,505 14,680 +2,825 Adjusted Earnings/(Loss) (Non-GAAP) 40,957 22,457 +18,500               3.72 3.48 +0.24 Earnings Per Common Share (U.S. GAAP) ¹ 8.18 5.16 +3.02               4.23 3.52 +0.71 Adjusted Earnings/(Loss) Per C...